Manage Immunization program Flashcards
Adenovirus Types 4 and 7
2 tablets
oral
Anthrax vaccine
Policy set by DoD and CG
.5 ML/IM
0, 4 w, 6m, 12m, 18m
Annual booster
Haemophilus Influenzae Type B (HIB)
.5ML/IM
1 dose
Hepatitis A
6 M-18 YO
.5ML/IM
0, 6M
19 YO >
1ML/IM
0, 6 M
Hepatitis B
“for bloodborne pathogen people”
0-19 YO
.5ML/IM
20 YO >
1ML/IM
0, 1M, 8W-16W
TWINRIX
1.0ML/IM
0, 4 W, 5 M
Influenza
1.0ML/IM
“don’t give if anaphylactic reaction”
Japanese Encephalitits (JE)
.5ML/IM
0, 7-28 D
booster one time at 11 M if needed.
Measles, Mumps and Rubella (MMR)
don’t get pregnant for at least 28 days.
.5ML/SQ
0, 4 W
Meningococcal
.5ML/IM
0, 2 M
Pneumococcal Conjugate (PCV 13)
.5ML/IM
Booster for those without spleens or severe immunocompromised
Poliomyelitis
.5 ML/SQ or IM
Rabies
post exposure. Considerations of species, circumstances, and type of exposure.
1.0ML/IM HDCV
0, 3D, 7D, 14D. 5th dose on 28D if immunocompromised
OR
20 international units of HRIG per Kg body weight, infiltrate around the wound.
Smallpox
15 jabs using bifurcated needle
Assess 6-8 days later for “Major Reaction vs No Take”
Route-Percutaneous
Tetanus, diphtheria, and pertussis (Tdap)
.5ML/IM
every 10 years